Theodore Robertson Pak, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock, Septic | 2 | 2023 | 775 | 1.120 |
Why?
|
Meta-Analysis as Topic | 2 | 2016 | 1340 | 0.750 |
Why?
|
Cross Infection | 5 | 2024 | 1416 | 0.740 |
Why?
|
Sepsis | 2 | 2023 | 2593 | 0.670 |
Why?
|
Communicable Diseases | 2 | 2016 | 880 | 0.580 |
Why?
|
Genomics | 5 | 2021 | 5714 | 0.570 |
Why?
|
Genome, Bacterial | 4 | 2020 | 757 | 0.550 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2015 | 16 | 0.530 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4803 | 0.510 |
Why?
|
Disease Management | 2 | 2016 | 2459 | 0.500 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2015 | 232 | 0.460 |
Why?
|
Computational Biology | 2 | 2016 | 3515 | 0.450 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3591 | 0.440 |
Why?
|
Quinolones | 1 | 2015 | 368 | 0.420 |
Why?
|
Clostridium Infections | 2 | 2019 | 548 | 0.410 |
Why?
|
Molecular Epidemiology | 2 | 2020 | 467 | 0.310 |
Why?
|
Bacteremia | 4 | 2020 | 963 | 0.260 |
Why?
|
Length of Stay | 1 | 2017 | 6311 | 0.240 |
Why?
|
Health Care Costs | 1 | 2017 | 3207 | 0.240 |
Why?
|
Electronic Health Records | 2 | 2017 | 4467 | 0.230 |
Why?
|
Disease Outbreaks | 3 | 2021 | 1771 | 0.210 |
Why?
|
Software | 2 | 2015 | 4440 | 0.210 |
Why?
|
England | 1 | 2023 | 522 | 0.210 |
Why?
|
Staphylococcal Infections | 3 | 2020 | 1400 | 0.200 |
Why?
|
Morphine | 1 | 2005 | 657 | 0.190 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 206 | 0.170 |
Why?
|
Chikungunya virus | 1 | 2018 | 50 | 0.160 |
Why?
|
Daptomycin | 1 | 2018 | 73 | 0.150 |
Why?
|
Enterococcus faecium | 1 | 2018 | 99 | 0.150 |
Why?
|
Nitric Oxide | 1 | 2005 | 2132 | 0.140 |
Why?
|
Hospitals | 4 | 2023 | 3953 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2020 | 687 | 0.140 |
Why?
|
Word Processing | 1 | 2015 | 7 | 0.130 |
Why?
|
New York | 1 | 2017 | 885 | 0.130 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7172 | 0.130 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2018 | 564 | 0.120 |
Why?
|
Vancomycin | 1 | 2018 | 501 | 0.120 |
Why?
|
DNA, Bacterial | 2 | 2019 | 1463 | 0.120 |
Why?
|
Microbial Sensitivity Tests | 2 | 2018 | 1870 | 0.110 |
Why?
|
Genes, Bacterial | 1 | 2017 | 1078 | 0.110 |
Why?
|
Oncogenic Viruses | 1 | 2012 | 42 | 0.110 |
Why?
|
Amyloid beta-Peptides | 1 | 2005 | 3587 | 0.110 |
Why?
|
Yeasts | 1 | 2012 | 284 | 0.100 |
Why?
|
Internet | 2 | 2015 | 3058 | 0.100 |
Why?
|
Propensity Score | 1 | 2017 | 1781 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1480 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1453 | 0.090 |
Why?
|
Workflow | 1 | 2015 | 847 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2023 | 5316 | 0.090 |
Why?
|
Genome, Human | 2 | 2012 | 4418 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 824 | 0.080 |
Why?
|
Trans-Activators | 1 | 2018 | 2927 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3850 | 0.080 |
Why?
|
Phylogeny | 3 | 2020 | 2796 | 0.080 |
Why?
|
Humans | 19 | 2024 | 743811 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1431 | 0.080 |
Why?
|
Tissue Donors | 1 | 2017 | 2241 | 0.080 |
Why?
|
Minisatellite Repeats | 1 | 2007 | 165 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3645 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2961 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2017 | 2119 | 0.070 |
Why?
|
Microsatellite Repeats | 1 | 2007 | 799 | 0.060 |
Why?
|
Viral Proteins | 1 | 2012 | 1899 | 0.060 |
Why?
|
Alzheimer Disease | 1 | 2005 | 8035 | 0.060 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2005 | 311 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1479 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2019 | 1121 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13404 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2023 | 77410 | 0.050 |
Why?
|
Endopeptidases | 1 | 2005 | 772 | 0.050 |
Why?
|
Time Factors | 1 | 2023 | 40038 | 0.050 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2005 | 584 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1213 | 0.050 |
Why?
|
Adult | 4 | 2023 | 213889 | 0.040 |
Why?
|
Spores, Bacterial | 1 | 2019 | 118 | 0.040 |
Why?
|
Genetic Variation | 2 | 2019 | 6535 | 0.040 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2019 | 186 | 0.040 |
Why?
|
Culicidae | 1 | 2018 | 104 | 0.040 |
Why?
|
Mutation | 3 | 2019 | 29777 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4749 | 0.040 |
Why?
|
Vancomycin Resistance | 1 | 2018 | 128 | 0.040 |
Why?
|
Adolescent | 3 | 2020 | 85729 | 0.030 |
Why?
|
Cricetinae | 1 | 2019 | 2475 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1802 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 56392 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2018 | 581 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1328 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2019 | 546 | 0.030 |
Why?
|
Aged | 4 | 2020 | 163178 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2019 | 778 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57744 | 0.030 |
Why?
|
Polyomavirus | 1 | 2012 | 249 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1836 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 464 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2009 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2005 | 13028 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 213241 | 0.020 |
Why?
|
Cell Lineage | 1 | 2018 | 2506 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2012 | 811 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16674 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 25609 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2593 | 0.020 |
Why?
|
Documentation | 1 | 2015 | 871 | 0.020 |
Why?
|
Male | 4 | 2020 | 349776 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1100 | 0.020 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2007 | 17 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6487 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2012 | 739 | 0.020 |
Why?
|
Female | 4 | 2020 | 380020 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2720 | 0.020 |
Why?
|
Infant | 2 | 2019 | 35122 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1041 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2012 | 1119 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12944 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2007 | 501 | 0.020 |
Why?
|
Animals | 4 | 2019 | 168660 | 0.020 |
Why?
|
Hospitalization | 1 | 2024 | 10259 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5251 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7324 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3474 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21675 | 0.010 |
Why?
|
Mice | 2 | 2019 | 81154 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12066 | 0.010 |
Why?
|
Models, Genetic | 1 | 2007 | 3492 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2007 | 2750 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8430 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9440 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 40964 | 0.010 |
Why?
|
Child | 1 | 2018 | 77637 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23398 | 0.010 |
Why?
|